Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines, Others) Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, Protease Inhibitors, Other Antivirals) The report covers both currently marketed and late stage development products. Revenues for each segment were generated using dollar and unit sales for each product. A novel approach in this report is that it provides revenue by product type but also the 'market' for treatments by type of infection, enabling marketers to research the best markets where a variety of products may be implemented. The report includes statistical information for infections by type worldwide, with special emphasis on the U.S. and Europe. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers.

1. World Market for Anti-Infectives: Antifungals,
Antibacterials and Antivirals (Treatments for
HIV, HBV, HCV, Urinary Tract, Respiratory,
Candidiasis and Other Infections)
Report Information: Executive Summary,
Competition, Marketing & Consumer &
Market Trends

2. About Us
MarketResearch.com is the world's largest and continuously updated collection of
market research. As your single source for market intelligence, we offer more than
300,000 market research reports from over 700 leading global publishers.
Our Research Specialists have in-depth knowledge of the publishers and the various
types of reports in their respective industries. They give you unbiased and qualitative
insights on which reports will best meet your needs.
Whether you’re looking for new product trends or competitive analysis of a new or
existing market, MarketResearch.com has the best research offerings and the expertise
to make sure you get the right report every time. Don’t limit your choices. See why
leading companies trust MarketResearch.com again and again to gain and maintain a
competitive edge in new and existing markets.

3. World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments
for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)
This Kalorama Information report – The World Market for Anti-Infectives - focuses on
three key segments of treatment:
 Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals)
 Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides,
Penicillins, Quinolones, Sulfonamides, Tetracyclines, Others)
 Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors,
Protease Inhibitors, Other Antivirals)
The report covers both currently marketed and late stage development products.
Revenues for each segment were generated using dollar and unit sales for each product.
A novel approach in this report is that it provides revenue by product type but also the
'market' for treatments by type of infection, enabling marketers to research the best
markets where a variety of products may be implemented.
The report includes statistical information for infections by type worldwide, with special
emphasis on the U.S. and Europe. The market segments provide an overview,
description of products on the market, description of products in development, market
estimates and forecasts, and competitive analysis of leading providers.

4. World Market for Anti-Infectives: Antifungals, Antibacterials and Antivirals (Treatments
for HIV, HBV, HCV, Urinary Tract, Respiratory, Candidiasis and Other Infections)
The area of anti-infectives represents an exciting frontier for development of potential life-
saving products. However, there are a number of issues and trends that have a direct
influence on this market and manufacturers' ability to successfully operate in the market.
The issues and trends affecting this market include:
 Drug Resistance
 HIV Trends, Cost, and Access to Drug Therapy
 Other Immunocompromised Population Issues
 Alliances and Partnerships
 New Developments
 Rx-to-OTC Switches
View Full Table of Contents

5. For More this Report and Additional Research
Visit MarketResearch.com
Or call
1-800-298-5699